Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click on 'Find out more' to see our Cookie statement.

Professor John B Goodenough from the Cockrell School of Engineering at The University of Texas at Austin has been awarded the Nobel Prize in Chemistry for his work at Oxford University that made possible the development of lithium-ion batteries.

Professor John Goodenough

He received the award jointly with Oxford DPhil graduate M. Stanley Whittingham and Akira Yoshino.

In 1980, during his time as Head of the Inorganic Chemistry Department at Oxford, Professor Goodenough, along with Koichi Mizushima, Philip C Jones and Philip J Wiseman, identified the cathode material that enabled development of the rechargeable lithium-ion battery. This breakthrough ushered in the age of portable electronic devices such as laptops and smartphones.

Professor Louise Richardson, Vice-Chancellor of the University of Oxford, said: 'We are delighted that a second Oxford discovery has been honoured with a Nobel Prize within a week. Professor John Goodenough’s discovery of cathode material here enabled the development of the lithium-ion battery, introducing the mobile phone era and transforming lives worldwide. Our warmest congratulations go to Professor Goodenough and also to Professor M Stanley Whittingham, who obtained his undergraduate and postgraduate degrees at Oxford. Today, we are continuing the work Professor Goodenough pioneered at Oxford with major programmes of research into lithium batteries and energy storage.'

Professor Steve Faulkner, Head of Inorganic Chemistry at the University of Oxford, said: ‘John Goodenough and his group pioneered the development of lithium cathode materials in Oxford; without this work, the rechargeable lithium battery (and arguably the modern connected world) would not exist. His decade in charge of the Inorganic Chemistry Laboratory at the University of Oxford created a field of research that continues to thrive here. Professor Goodenough is distinguished by making notable contributions to scientific knowledge in every decade since the 1950s, crossing disciplines and defining new ones.’ 

John Goodenough and his research group
John Goodenough (front row, second from right) with his colleagues at Oxford in 1982, two years after creating the cobalt-oxide cathode. Image courtesy of John Goodenough

In May 2019, Professor Goodenough was also awarded the Royal Society’s Copley Medal, the world’s oldest scientific prize. He is a fellow of the Royal Society and is an Honorary Fellow of St Catherine's College, Oxford.The news of the Chemistry Nobel Prize follows the award of the 2019 Nobel Prize in Physiology or Medicine to Professor Sir Peter J Ratcliffe, Director for the Target Discovery Institute within the Nuffield Department of Medicine at Oxford University and Director of Clinical Research at Francis Crick Institute, London.

Joint winner, M. Stanley Whittingham of Binghamton University, State University of New York, USA, was an undergraduate and graduate student in Inorganic Chemistry in Oxford, and his work on lithium titanium sulfide battery cathodes laid the foundations for Goodenough’s later developments.

On Monday, Professor Sir Peter J Ratcliffe, Director for the Target Discovery Institute within the Nuffield Department of Medicine at Oxford University and Director of Clinical Research at Francis Crick Institute, London, was announced as a winner of the Nobel Prize in Physiology or MedicineSir Peter was announced as a winner of the Prize alongside William G Kaelin, Jr of Harvard University and Gregg L Semenza of Johns Hopkins University. Together they discovered the key mechanisms that our cells use to detect and respond to low oxygen levels, known as 'hypoxia'. Sir Peter has a long-standing collaboration with groups in the Department of Chemistry.

Story courtesy of the University of Oxford News Office and the Department of Chemistry

 

Similar stories

A unique international ‘zoom’ collaboration to develop treatments for COVID-19

An international collaboration of 29 scientists around the world has focused on understanding how SARS-COV-2 makes its worker proteins at the molecular level in order to develop novel antiviral drugs that block their production.

Eight Oxford researchers win top UKRI Future Leaders Fellowships

Five of the new Fellows are from MPLS Division. The Fellowships have been created by UKRI to help develop the next wave of world-class research and innovation leaders in academia and business.

Reducing children’s exposure to malaria in their early years substantially cuts the risk of hospitalisation

For the first time in more than two decades, a team from the KEMRI-Wellcome Trust Research Programme and University of Oxford (including Department of Zoology researchers) have quantified the risk of children suffering severe outcomes from malaria.

AI test screens for COVID-19 26% faster than lateral flow tests

An Artificial Intelligence (AI) test performed by the bedside in 10 minutes quickly and safely triages patients coming to hospital for COVID-19, a University of Oxford-led study has shown.

How to design an icosahedral quasicrystal through directional bonding

Professor Jonathan Doye from the Department of Chemistry writes about his research.